ArticleGels (Basel, Switzerland)2026
AgNPs-Cellulose Nanofiber/Polyacrylamide Hydrogels as an Antibacterial Platform for Soft Tissue.
Article in Gels (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
Modern wound care is challenged by the emergence of antibiotic-resistant bacterial strains, causing the need for advanced dressing materials that provide infection control while promoting healing. Although polyacrylamide (PAAm) hydrogels are widely investigated due to their biocompatibility, their lack of intrinsic antibacterial activity and poor mechanical properties restrict their clinical use. To overcome these limitations, this study proposes a natural-synthetic hydrogel that combines PAAm with TEMPO-oxidized cellulose nanofiber (TOCNF) functionalized silver nanoparticles (AgNPs). The synthesis is performed through the polymerization of the synthetic monomer in the presence of the TOCNF-AgNPs, the nanofibrillar cellulose simultaneously serving as a reducing and stabilizing agent for AgNPs, and as a plasticizer for the PAAm network. Morpho-structural analysis of the hybrid precursor (TOCNF-AgNPs) revealed two populations of AgNPs, offering a cumulative effect between rapid bacterial penetration and a prolonged ionic reservoir, while maintaining the stability of the system. The subsequent incorporation of the hybrid into PAAm matrix resulted in tunable swelling kinetics and mechanical properties. Wettability and surface stiffness improve with the increase in hybrid content. The antibacterial effect was confirmed by a colony-counting assay for formulations with higher AgNPs content, exhibiting inhibitory metabolic activity against several pathogenic strains. These results suggest that PAAm/TOCNF-AgNPs (PTA) nanocomposites represent a promising mechanically adaptive candidate for wound-care applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.